treb web vieweffectiveness of rational emotive behavior therapy on ... several theoretical...
TRANSCRIPT
Effectiveness of Rational Emotive Behavior Therapy on Attendance and
Psychopharmacological Agents Prescription
Main Author: Carme Rovira Aler (a), Coauthors: María Isabel Fuentes Leiva (b), Jesús Almeda Ortega(c), Xavier Fernandez Bonet (d), Oriol Cunillera Puertolas (e), Silvia Edo Izquierdo (f)
a. Social Worker, MSc Research in Health Psychology, Catalan Institute of Health, PCC Sant Andreu, Barcelona, Spain
b. GP, Catalan Institute of Health, PCC Martorell, Barcelona, Spain,
c.MD, PhD, Catalan Institute of Health, Research Support Unit Costa de Ponent, Primary Care University Research Institute Jordi Gol (IDIAP Jordi Gol). PCC Cornellà. Cornellà de Llobregat, Spain.
d. GP, Catalan Institute of Health, PCC Sant Llehy, Barcelona. Spain.
e. Msc Statistics, Research Support Unit Costa de Ponent, Primary Care University Research Institute Jordi Gol (IDIAP Jordi Gol) PCC Cornellà. Cornellà de Llobregat, Spain.
f.PhD in Psychology, Universitat Autònoma de Barcelona. Cerdanyola del Vallès, Spain.
Correspondence to: Carme Rovira Aler [email protected].
Presentation
The aim of our study is to evaluate the effectiveness of a psychosocial interven-
tion in dysthymia patients to reduce attendance to primary care, mental health
and social services and use of psychopharmacological agents. In this study,
clinical social workers have administered Rational Emotive Behavior Therapy
(REBT) in the context of a primary care center. Indeed, the care of patients with
emotional disorders is amongst the responsibilities of social health workers in
Catalonia, and while this type of intervention is common practice, the results are
rarely evaluated. Literature on clinical social work with REBT is scant; more-
over, it is mostly theoretical work where scientific evidence applies to very di-
verse populations. With the evaluation of this psychosocial intervention, our arti-
cle aims to disseminate this aspect of social health workers within primary care,
mental health and social services.
Abstract
Objective: The healthcare costs of patients with dysthymic disorders are high
due to frequent attendance and to high prescription rates of
psychopharmacological agents. The objective of this study is to evaluate the
effectiveness of Rational Emotive Behavior Therapy (REBT) administered by a
social worker (SW) in patients with dysthymia (Intervention Group, IG) in
reducing primary care attendance and prescription of psychopharmacological
agents when compared with standard care (Control Group, CG).
Methods: Non-randomized clinical trial with a 12-month follow-up period.
Analysis was performed using logistic regression adjusted for propensity
scores.
Results: The reduction in attendance was 47.9% in the CG (n=39) and 77.5% in
the IG (n=51) (OR=3.75, p=0.021). The proportion of patients with a reduced
prescription of psychopharmacological agents was 11.4% in the CG and 47.8%
in the IG (OR=7.14, p=0.006).
Conclusions: REBT decreases the proportion of patients that need prescription
of psychopharmacological agents and frequent attendance to social and
primary care.
Clinical Trials Registry Number: IDNCT02112708
Keywords: Rational Emotive Behavior Therapy; Dysthymia; Social Work;
Propensity scores; Primary Health Care
Introduction
Over 70% of mental health problems are exclusively managed in Primary Care
(PC). The yearly prevalence of depression and anxiety in PC patients in
Catalonia is 30% in women and 14% in men [1]. Serrano-Blanco et al. (2010)
[2] showed a prevalence of 9.6% for major depressive disorder and of 3.1% for
dysthymia in Primary Care Centers (PCC) in our setting. In Mental Health
Centers of Barcelona, the prevalence of major depressive disorder and of
dysthymia is 1.3/1000 and 1.9/1000, respectively [3].
As a consequence of their emotional distress, patients with dysthymia are
typically frequent users of social and medical services and are often prescribed
psychopharmacological agents, which results in an increased risk of
chronification and high pharmacy costs [4].
The National Association of Social Workers has defined the role of the clinical
social worker in the management of dysthymic disorders [5]. For over 10 years
now, PCC have implemented psychoeducational group interventions for
patients with anxiety and depression. The measure has proven to be on the
short and long term effective in patients with mild depression at the national [6]
and international level [7, 8]. Individual treatment achieves similar results [9].
The responsibilities of the Catalan Health Institute (CHI) primary care Social
Worker (SW) include the individual management of patients with emotional
disorders referred by health professionals. Following the recommendations of
the National Institute for Health and Care Excellence [10], World Health
Organitation [11] and other authors [12, 13], SW use interventions based on
Cognitive Behavioral Therapy to provide individual psychosocial care. In
particular, they use Rational Emotive Behavior Therapy (REBT), which has
been tested by psychologists and psychiatrists in patients with different
conditions and from different settings [14, 15]. In REBT, emotions and behavior
are believed to originate in the beliefs and the interpretation of reality of the
individual. To promote more adaptive emotions and behavior, the therapist
helps the patients identify their dysfunctional beliefs and thoughts by means of
written records and psychological sessions.
Though evidence in medical literature on the subject is still scant, several
theoretical publications present an updated overview of REBT for medical social
workers [16].
In addition to its social and scientific interest, REBT as implemented by medical
social workers was introduced in Catalonia in 2000 with the main aim to provide
self-help tools for patients with mild psychiatric disorders associated to the
resolution of everyday life problems.
An observational, descriptive study was carried out in 2008 in the primary care
services of Martorell (Barcelona) with 37 patients diagnosed of depression,
anxiety and bereavement. After the REBT sessions, the average number of
visits to the PCC decreased from 11.4% (SD 11.2) to 1.3% (SD 1.7). In addition,
the use of psychopharmacological agents also diminished: sedative-hypnotics
from 53.8% to 7.7% and anxiolytic agents from 69.2% to 23.1% [17].
This study aims to evaluate the effectiveness of REBT as implemented by
medical SW in decreasing attendance to health services and the prescription of
psychopharmacological agents in patients with dysthymia after a year of follow-
up.
Methods
Design: Non randomized clinical trial. The intervention group received REBT by
the purposely trained SW and the control group the standard medical care by
their General Practitioner (GP).
Participants were patients with a diagnosis of dysthymia according to the
Diagnostic and Statistical Manual of Mental Disorders–IV (DSM-IV), recruited
from two PCC with similar sociodemographic characteristics in the Barcelona
metropolitan area. Inclusion criteria were: patients over 14 years of age with a
registered diagnosis of dysthymia by their GP in the electronic medical records
(EMR). Exclusion criteria were: cognitive impairment, illiteracy, refusal of
treatment, severe psychiatric disorder and participation in psychoeducational
groups and similar therapies.
Sample size calculation was estimated based on the least favorable comparison
between the two outcome variables, which assumed a final proportion of
sedative-hypnotic drug intake of 8% in the IG group and 37% in the CG. With a
5% significance level, 80% statistical power and a case-control ratio of 1:1 with
a predicted drop-out rate of 20%, the estimated sample size per group was 50
individuals in the CG group and 50 in the IG.
Study period from October 2009 to May 2013.
Outcome variables: frequency of use of primary care services related to the
diagnosis of dysthymia and prescription of psychopharmacological agents
(sedative-hypnotics, antidepressants and anxiolytic drugs) as registered in the
EMR during the previous 12 months.
The frequency of visits to PC was categorized as “improvement” and “no
improvement”. “Improvement” means a lesser number of visits in comparison to
the previous year, comparing baseline data with data after a 12-month follow
up. An improvement in the prescription of sedative-hypnotics, antidepressants
and anxiolytic drugs was considered when baseline prescription was higher
than after the 12-month follow up.
Other study variables: sociodemographic variables, group (IG/CG), level of
education (primary/secondary and further), living arrangements (lives on his/her
own/with other people), Beck Depression Inventory (BDI) [18] and comorbidities
at baseline. Comorbidities included chronic conditions such as: hypertension,
diabetes, dyslipidemia, asthma, chronic obstructive pulmonary disease, heart
failure, ischemic heart disease, cerebrovascular disease, cancer, thyroid
disease, liver disease, fibromyalgia and musculoskeletal disorders.
Recruitment and data collection are shown in Figure 1.
The professionals in charge of recruitment received a one hour training session
with a psychiatrist to guarantee the diagnosis and comparability between
groups.
Patients of the IG were recruited in a PCC (Sant Andreu, Barcelona) different
from the PCC where the CG patients were recruited (Martorell) to prevent
contamination bias from the possible REBT effects. In the IG, the GP
systematically referred to the SW all patients with inclusion criteria during the
study period. The GP treated the CG as usual. All patients signed the informed
consent form at baseline
The number of visits to PCC and data on prescription of psychopharmacological
agents was obtained from the EMR in both groups. Other information was
obtained during the interviews at baseline and after 4 and 12 months. The data
collection forms and the database were anonymized to guarantee
confidentiality; a list that could link the cases with the real names was securely
kept.
The SW carried out the individual psychosocial intervention, with a maximum of
8 fortnightly sessions of 30 minutes. Each session aimed at identifying and
analyzing the dysfunctional thoughts of the patients in order to suggest healthier
alternatives. The information about intervention was assessed at baseline and
during de last visit by the SW.
Analysis: The study data were entered systematically in a Microsoft Access
database to facilitate the correction of discrepancies in data entry. Categorical
variables distributions are described by absolute and relative frequencies.
Continuous variables are described by their means and standard deviations.
Baseline data from participants in the IG and CG were compared using a chi-
square test (proportions of categorical variables) and the t-test (mean of
continuous variables).
To compensate baseline differences between the CG and the IG caused by the
non-randomization of participants, we used propensity scores (PS) [19]. PS
were validated by PS-adjusted baseline characteristics balance -by linear and
logistic regression models-, discrimination ability between treatment groups -
using Receiver Operating Characteristic (ROC) curves, and area under the
ROC-, and appropriate distribution for the PS (histogram).
Two logistic regression analyses with adjustment for the PS (introduced as
continuous variables or by quintiles) were carried out to evaluate the effect of
the intervention in the improvement of attendance and of prescription of
psychopharmacological agents. All analyses were carried out by intention-to-
treat and per-protocol (results of the per-protocol analyses are only shown as
supplementary material). For the per-protocol analysis, the intervention was
considered finished when after a minimum of 3 sessions the SW perceived
clinical improvement, confirmed by a decrease in the score of the BDI post-
intervention or by the patient him or herself acknowledging improvement.
All statistical analyses were performed using the statistical package R
(Foundation for Statistical Computing, Vienna, Austria).
All graphics were perfomed using the MS Office Visio.
Ethics: This study was approved by the Ethics Committee of the Primary Care
University Research Institute (IDIAP) Jordi Gol (Protocol Number: 13/035).
Clinical Trials Registry number IDNCT02112708.
Results
A total of 79 and 50 patients were included in the IG and CG, respectively. Of
those, 16 in the IG and 11 in the CG did not attend their first visit. In addition, in
the intervention group 12 patients were found to meet exclusion criteria; there
were no exclusions in the CG (Figure 1).
The average number of REBT sessions in the IG was 5.2 (SD 2.25); 9 patients
(17.7%) attended fewer than 3 sessions. A total of 77 patients completed the
study, 39 in the IG and 38 in the CG.
Of the total participants, 92.2% were women, with a mean age at the start of the
study of 62.9 years (SD 12.4). With regard to education, 60% had attended
primary school and 34.4% secondary schooling and further education; 21.6% of
participants lived on their own and 88.9% used some psychopharmacological
agents. The average number of visits to primary care services was 3.2 (SD 2.9),
mean prescription of psychopharmacological agents was 1.5 (SD 0.8) during
the previous year, and average number of chronic diseases 3.5 (SD 1.8) at the
start of the study.
Table 1 compares the baseline characteristics by intention-to-treat between the
CG and the IG with PS adjustment. Before adjusting for PS, educational level
and frequency of yearly visits to the GP were significantly higher in the IG,
whereas baseline comorbidity was significantly higher in the CG.
Table 1. Comparative analysis of baseline characteristics by treatment group,
raw and adjusted by Propensity Score (Intention-to-treat analysis)
Control Group
Intervention Group p
Intervention Group adj.
Control Group adj. Adj. P
n % n % % %Male 5 12.8 2 3.9 4.3 4.6Female 34 87.2 49 96.1 95.7 95.4Primary Schooling 32 82.0 27 52.9 75.9 71.0Secondary schooling and University
7 17.9 24 47.1 24.1 29.0
Lives on his/her own 5 13.5 14 27.4 18.2 18.4Lives with other people 32 86.5 37 72.5 81.8 81.6no treatment 4 10.3 6 11.7 12.5 9.1Treatment 35 89.7 45 88.2 87.5 90.9no 28 71.8 44 86.2 83.4 82.8yes 11 28.2 7 13.7 16.6 17.2no 7 17.9 8 15.7 18.7 15.1yes 32 82.0 43 84.3 81.3 84.9no 17 43.6 28 54.9 53.1 47.4yes 22 56.4 23 45.1 46.9 52.6
Mean SD Mean SD p Adj.mean Adj.mean Adj. P
65.5 13.2 60.8 11.5 0.085 64.9 61.3 0.2642.2 2.7 4.0 2.9 0.002 2.9 3.4 0.5461.7 0.9 1.4 0.8 0.192 1.5 1.6 0.64822.2 11.7 24.5 9.9 0.310 23.0 23.8 0.7674.3 2.1 2.9 1.2 <0.001 3.6 3.4 0.607
SD:Standard DeviationAdj: Adjusted
Beck Depression Inventory Score at baselineNumber of Comorbidities
Anxiolytic0.395 0.667
AgeNumber of visits to GP during previous yearNumber of psycopharmacological agents at baseline
0.9520.151Sedative-Hypnotics
Antidepressants1.000 0.706
0.9840.191Living arrangements
0.6521.000Psycopharmacological agents baseline
0.244 0.941Gender
Educational Level 0.008 0,674
To obtain the PS we calculated a logistic regression model to predict the
allocation to treatment group (Table A.1 in the supplementary material). The
resulting PS are adequate to control for imbalances in baseline characteristics,
as shown in Table 1, with a correct discrimination between treatment groups
(AUC: 0.823; 95%CI: [0.737, 0.909]; Figure A.1 in the supplementary material),
a plausible overlap between both groups (Figure A.2 and Table A.2 in the
supplementary material), and a representation of both groups in all the PS
quintiles.
After adjustment for PS and taking into account the whole sample, a decrease
of attendance was observed in 55 (65.3%) patients and a reduction in
prescription of psychopharmacological agents in 25 (31.1%) patients.
Table 2 shows the results of the regression model adjusted for PS, entered in
the model as a continuous variable, both for reduction in attendance and for
prescription of psychopharmacological agents; the improvement in relation to
attendance and prescription of psychopharmacological agents is higher in the
IG (OR = 3.75, 95%CI 1.23-11.83, p = 0.021; and OR = 7.14, 95%CI 1.91-
33.46, p = 0.006, respectively).
Table 2. Results of logistic regression models adjusted by Propensity Score
(introduced as a continuous variable) evaluating the effect of the intervention
(intention-to-treat analysis) on improvement of frequent attendance and
prescription of psycopharmacological agents
OR P value OR P valueIntervention Group 3.75 (1.23, 11.83) 0.021 7.14 (1.91, 33.46) 0.006
Propensity score 2.13 (1.18, 3.99) 0.014 0.99 (0.52, 1.86) 0.982
Intercept 0.92 (0.42, 2.01) 0.832 0.13 (0.04, 0.35) 0.000
Improvement frequent attendanceImprovement prescription of
psychopharmacologycal agents
This model shows that the expected proportion of patients with a decrease in
attendance adjusted for PS was 47.9% in the CG and 77.5% in the IG, and the
decrease in prescription of psychopharmacological agents was 11.4% and
47.8%, respectively.
Similar results were obtained by adjusting the model with the introduction of the
PS by quintiles (Table A.3 in the supplementary material).
Finally, the supplementary material includes the results of the same analyses
carried out per-protocol: baseline comparison of CG and IG (Table A.4 in the
supplementary material), logistic regression with continuous PS (Table A.5 in
the supplementary material), and logistic regression with PS by quintiles (Table
A.6 in the supplementary material).
Discussion
The results of this study indicate that REBT carried out by clinical Social Worker
is effective in the treatment of dysthymia, as reflected in the decreased use of
psychopharmacological agents and consequently, the expected decreased
derivation to social services and mental health care services.
Based on the adjusted results, standard medical care and standard prescription
of psychopharmacological agents decrease number of visits in 47.9% of
patients. With REBT, another 29% is added to this percentage. The reported
percentage of patients that reduces the prescription of sedative-hypnotics,
antidepressants and anxiolytic drugs with standard medical care and
prescription is 11.4%. With REBT, this proportion increases four-fold. In
conclusion, this study shows a significant decrease in the number of visits and
in the prescription of psychopharmacological agents after a year of the REBT
intervention, both in the intention-to-treat and the per-protocol analyses.
While numerous studies have previously used prescription of
psychopharmacological agents and frequency of visits as outcome measures in
cost-effectiveness studies of different psychological interventions, [20, 21], no
studies have been published to date on the effectiveness of REBT in relation to
these indicators in patients with dysthymia. The results of this study show that
these indicators are adequate to evaluate the efficacy of REBT in patients with
dysthymia.
Most studies that evaluate the effectiveness of REBT use improvement in the
BDI as outcome measure. These studies show a higher effectiveness of REBT
when compared with standard medical care and prescription in patients with
depression [22-25]. The results of our study on the use of health resources
complement this evidence of the improvement with REBT as perceived by
patients with a diagnosis of dysthymia. Indeed, the results of this intervention
are similar to those published in a previous study in patients with anxiety and
depression that did not have a control group [17].
The aim of our intervention is to empower the patient so that they achieve a
greater autonomy to solve everyday conflicts within the health-disease process.
Indeed, whereas psychopharmacological agents might provide short-term
benefits, REBT is expected to have a medium-long term effect. We have not
found other studies that compare the effectiveness of REBT with standard
medical care and prescription of psychopharmacological agents after a year of
follow up.
Most clinical social work investigations face the challenge to conduct
randomized clinical trials [26]. While randomized trials are ideal designs to infer
causality, often this type of design is unsuited for the social sciences.
Propensity scores are now a commonly used statistical technique. The
adjustment of baseline differences between groups has allowed to eliminate
bias in the estimation of the potential effects of the intervention [19]. However,
this methodology does not allow to adjust for possible differences between
groups according to other variables not studied. Some of these variables have
not been taken into account in our study, for instance the expectations of
patients in relation to therapy and the doctor-patient relationship, which is
known to reduce attendance [27] and psychopharmacological prescription.
These factors must be taken into account in future research to optimize the
balance between groups.
Conclusion
This study shows that the SW can assume the implementation of REBT in
primary care obtaining integrated approach between primary care, social and
mental health services. REBT translates into a great improvement in the
healthcare of the patient with dysthymia, which is usually on chronic medication
and not usually prioritized by mental health specialists. Additionally, REBT
would also increase the efficiency of PCC. Following the initiative of several
universities in the USA, [28] we suggest for REBT to be included in the training
program of SW so that they are prepared to deliver REBT when required by
their colleagues in Social services an Primary Care.
Taking into account a broader, biopsychosocial perspective on health, further
studies on the effectiveness of REBT to improve quality of life and mood states
are needed. Also, patient perception of REBT should be evaluated and the
qualitative and quantitative results compared by means of methodological
triangulation [29]. Finally, cost-effectiveness of REBT in the medium and long
term in PC must be determined.
Acknowledgement
The study was financed by the Catalan Institute of Health, Research Grants XB
of the Barcelona Research Support Unit, 2008 Call for Proposals.
The fieldwork was carried out in the context of the everyday activities of the pri-
mary care centers from October 2009 to May 2013. This study was partially pre-
sented in the Research Workshop XB of the Catalan Institute of Health, March
2014; in the VIII Meeting of Mental Health and Primary Care of the Catalan So-
ciety of Family and Community Medicine (CAMFIC), May 2014; in the 1 Innova-
tion Day of the Catalan Institute of Health, March 2015; in the 35th Meeting of
the Spanish Society of Family and Community Medicine (SEMFYC) in Gijón,
Asturias, June 2015, in the 10th Meeting IDIAP Jordi Gol in Barcelona, April
2016 and the 16th International Conference on Integrated Care in Barcelona,
May 2016.
Ethical approval: This study was approved by the Ethics Committee of the Pri-
mary Care University Research Institute (IDIAP) Jordi Gol (Protocol Number:
13/035). All procedures were in accordance with the ethical standards of the
1964 Helsinki declaration and its later amendments. Clinical Trials Registry
number IDNCT02112708.
Informed Consent: Informed consent was obtained from all individual
participants included in the study.
Conflict of Interest: The authors declare that they have no conflict of interest.
All authors have taken part in drafting the manuscript and in the design, devel -
opment and final writing of the study.
We thank the management of the primary care centers for their active support.
Also, we thank the Research Support Unit of the Primary Care Management
Costa de Ponent of the Catalan Institute of Health for the methodological and
statistical support. Finally, we are grateful to the Primary Care Research Insti-
tute-IDIAP Jordi Gol for the translation of the manuscript into English.
References
1 Departament de Salut Generalitat de Catalunya. Pla salut 2011- 2015.[Health Plan]. Generalitat de Catalunya. Barcelona. 2012. Retrieved from http://www20.gencat.cat/docs/salut/Home/Destaquem/ Documents/plasalut_vfinal.pdf. [in catalan].
2 Serrano-Blanco A. Palao D. J. Luciano J. V. Pinto-Meza A. Luján L. Fernández A. Haro J. M. Prevalence of mental disorders in primary care: Results from the diagnosis and treatment of mental disorders in primary care study (DASMAP). Social Psychiatry and Psychiatric Epidemiology, 2010; 45(2), 201–210, doi:10.1007/s00127-009-0056-y.
3 Area integral de Salut Barcelona Nord. Consorci Sanitari de Barcelona. Ruta Assistencial del Trastorn Depressiu.[ Health care route for depressive disorder].Barcelona. 2012. Retrieved from http://www.saveva.com/domamCons/pub/botss/html/ca/dir2887/doc33876.html.[in catalan].
4 Chiles J. A. Lambert M. J. Hatch A. L. The Impact of Psychological Interventions on Medical Cost Offset: A Meta-analytic Review. Clinical Psychology: Science and Practice, 1999; 6(2), 204–220, doi:10.1093/clipsy.6.2.204.
5 Barker R. L. The Social Work Dictionary. Washington, DC: NASW Press. 2003.
6 Casañas R. Catalán R. del Val J. L. Real J. Valero S. Casas M. Effectiveness of a psycho-educational group program for major depression in primary care: a randomized controlled trial. BMC Psychiatry, 2012; 12, 230. doi:10.1186/1471-244X-12-230.
7 Cramer H. Salisbury C. Conrad J. Eldred J. Araya R. Group cognitive behavioural therapy for women with depression: pilot and feasibility study for a randomised controlled trial using mixed methods. BMC Psychiatry, 2011; 11, 82. doi:10.1186/1471-244X-11-82.
8 Pai B. N. Vella S. L. The importance of primary care psychiatry: an Australian perspective with global implications. Journal of Primary Care & Community Health, 2011; 2(4), 277–284. doi:10.1177/2150131911409753; 10.1177/2150131911409753.
9 Ibáñez-Tarín C. Manzanera-Escartí R. Técnicas cognitivo-conductuales de fácil aplicación en atención primaria (I).[ Easy applications of congitive behavioral techniques in primary care].Semergen, 2012; 38(6), 377–387. doi:10.1016/j.semerg.2011.07.019.[in spanish].
10 National Institute for Health and Care Excellence. Depression in adults: the treatment and management of depression in adults. NHS. 2009. Retrieved from http://publications.nice.org.uk/depression-in-adults-cg90.
11 OMS. La Depresión. [The Depression].Centro de Prensa. Nota descriptiva Nº 369. Octubre de 2012. Retrieved from http://www.who.int/mediacentre/factsheets/fs369/es/.[in spanish].
12 Shearer S. L. Recent Advances in the Understanding and Treatment of Anxiety Disorders. Primary Care - Clinics in Office Practice, 2007; 34(3), 475–504, doi:10.1016/j.pop.2007.05.002.
13 Ekers D. M. Lovell K. Playle J. F. The use of CBT based, brief, facilitated self-help interventions in primary care mental health service provision: Evaluation of a 10-day training programme. Clinical Effectiveness in Nursing, 2006; 9(SUPPL. 1), e88–e96. doi:10.1016/j.cein.2006.06.001.
14 Ellis A. Dryden W. Rational-emotive therapy: an excellent counseling theory for NPs. The Nurse Practitioner, 1987; 12(7), 16–21, 24, 29–32 passim. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/3614778.
15 Stanley M. A. Wilson N. L. Novy D. M. Rhoades H. M. Wagener P. D. Greisinger A. J. Kunik M. E. Cognitive behavior therapy for generalized anxiety disorder among older adults in primary care: a randomized clinical trial. JAMA : The Journal of the American Medical Association, 2009; 301(14), 1460–1467. doi:10.1001/jama.2009.458.
16 Ronen T. Freeman A. Cognitive Behavior Therapy in Clinical Social Work Practice. NY: Springer publishing company. 2007.
17 Rovira C. Fuentes M. Evaluación de la terapia racional emotiva comportamental como técnica de intervención en una consulta de Trabajo Social.[Assessment rational emotive behavioral therapy as an intervention technique in social work service]. Atención Primaria de Salud. Trab. Soc. y Salud. 2009; 63, 129–145. [in spanish].
18 Conde V. Esteban T. Useros E. Revisión crítica de la adaptación castellana del Cuestionario de Beck.[Critical review of the Spanish adaptation of the Beck Questionnaire]. Revista de Psicologia General y Aplicada, 1976; 31, 469-497. [in spanish].
19 Austin P. C. An Introduction to Propensity Score Methods for Reducing the Effects of Confounding in Observational Studies. Multivariate Behavioral Research. 2011; 46(3), 399–424. doi:10.1080/00273171.2011.568786.
20 Vicens C. Socias I. Mateu C. Leiva A. Bejarano F. Sempere E. Fiol F. Comparative efficacy of two primary care interventions to assist withdrawal from long term benzodiazepine use: a protocol for a clustered, randomized clinical trial. BMC Family Practice, 2011; 12(23). doi:10.1186/1471-2296-12-23.
21 Smits F. T. M. Wittkampf K. A. Schene A. H. Bindels P. J. E. Van Weert H. C. P. M. Interventions on frequent attenders in primary care. A systematic literature review. Scandinavian Journal of Primary Health Care, 2008; 26(2), 111–116, doi:10.1080/02813430802112997.
22 Siddique J. Chung J. Y. Brown C. H. Miranda J. Comparative Effectiveness of Medication Versus Cognitive-Behavioral Therapy in a Randomized Controlled Trial of Low-Income Young Minority Women With Depression. Journal of Consulting and Clinical Psychology, 2012; 80(6), 995–1006, doi:10.1037/a0030452.
23 David D. Szentagotai A. Lupu V. Cosman D. Rational emotive behavior therapy, cognitive therapy, and medication in the treatment of major depressive disorder: A randomized clinical trial, posttreatment outcomes, and six-month follow-up. Journal of Clinical Psychology, 2008; 64(6), 728–746. doi:10.1002/jclp.20487.
24 Serfaty M. Haworth D. Blanchard M. Buszewicz M. Murad S. King M. Clinical Effectiveness of Individual Cognitive Behavioral Therapy for Depressed Older People in Primary Care A Randomized Controlled Trial. 2009. Retrieved from http://discovery.ucl.ac.uk/170243/.
25 Hange D. Björkelund C. Peterson E. Use of antidepressants among depressed treated with internet-based Cognitive Behaviour Therapy. (2013).International Journal Integrated Care, 13(november). Retrieved from http://www.euprimarycare.nl/istanbul/conference-programme-efpc-2013-istanbul-results
26 Barth R. P. Shenyang G. McCrae J. S. Propensity Score Matching Strategies for Evaluating the Success of Child and Family Service Programs. 2008. Research on Social Work Practice, 18(3), 212-222. doi:10.1177/1049731507307791.
27 Renaud J. Russell J. J. Myhr G. The association between positive outcome expectancies and avoidance in predicting the outcome of cognitive behavioural therapy for major depressive disorder. British Journal of Clinical Psychology, 2013; 52(1), 42–52. doi:10.1111/j.2044-8260.2012.02044.x.
28 Boston University. The Master of Social Work (MSW) Program in Clinical Practice. 2016. Retrieved from http://www.bu.edu/academics/ssw/courses/clinical-practice/.
29 Cantor G. La triangulación metodológica en ciencias sociales. Reflexiones a partir de un trabajo de investigación empírica. Cinta Moebio, 2002; 13, 58–69. Retrieved from http://www.revistas.uchile.cl/index.php/CDM/article/viewFile/26186/27478.